News & Events
Learn more about TriNetX through media coverage and upcoming events
News & Events
Learn more about TriNetX through media coverage and upcoming events
Press Releases
TriNetX Executes Agreement to Revolutionize Clinical Trial Design to Enhance and Accelerate the Development of New Drugs
CAMBRIDGE, March 3, 2016 – TriNetX, a leader in international clinical research networks, announced today the signing of a collaboration agreement with Novartis to optimize clinical trial design and advance clinical research for Novartis programs. Novartis researchers...
Blog
Harnessing Real-World Data to Revolutionize Chronic Lymphocytic Leukemia Research
Chronic Lymphocytic Leukemia (CLL), a type of slow-growing cancer of the blood and bone marrow, accounts for 25-30 percent of all leukemia in the Western world and is the most common type of...
Recent Scientific Publications
Harrison, S. Fazio-Eynullayeva, E., Lane, D., Underhill, P., Lip, G. “Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19.” Published in Journal of Arrhythmia, 11 December 2020.
Applebaum, L., Berg, A., Cambronero, J., Dang, T., Jin, C., Zhang, L., Palchuk, M., Kundrot, S., Evans, L., Kaplan, I., Rinard, M. “Development of a pancreatic cancer prediction model using a multinational medical records database.” Journal of Clinical Oncology 2021 39:3_suppl, 394-394. 22 January 2021.
Pakhchanian, H., Raiker, R., Mukherjee, A., Khan, A., Singh, S., Chatterjee, A. “Outcomes of COVID-19 in CKD Patients.”. CJASN Feb 2021, CJN.13820820; DOI: 10.2215/CJN.13820820. February 2021.
Webinars
Closing Gaps in Patient Diversity Within Clinical Trials Using Real-World Data
March 24, 2021
Watch On-Demand
Learn How to Utilize COVID-19 Vaccination Data Available on the TriNetX Platform
February 24, 2021
Watch On-Demand